Cargando…

Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events

OBJECTIVE: aPL are found in the blood of 20–30% of patients with SLE. Although aPL cause vascular thrombosis in the antiphospholipid syndrome, it is not clear whether positive aPL levels in early SLE increase risk of subsequent vascular events (VE). In a previous analysis of 276 patients with SLE, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farina, Nicola, Abdulsalam, Ruya, McDonnell, Thomas, Pericleous, Charis, D’Souza, Amrita, Ripoll, Vera M, Webster, Jemma, Isenberg, David A, Giles, Ian, Rahman, Anisur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234200/ https://www.ncbi.nlm.nih.gov/pubmed/36227113 http://dx.doi.org/10.1093/rheumatology/keac596

Ejemplares similares

Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?
por: Pericleous, Charis, et al.
Publicado: (2020)

Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome
por: Artim-Esen, Bahar, et al.
Publicado: (2017)

Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
por: McDonnell, Thomas, et al.
Publicado: (2018)

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome
por: Ripoll, Vera M., et al.
Publicado: (2018)

Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays
por: Artim-Esen, Bahar, et al.
Publicado: (2015)

Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia/reoxygenation injury model via p38 MAPK
por: Bourke, Lauren T, et al.
Publicado: (2017)

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
por: Segura, Beatriz Tejera, et al.
Publicado: (2019)

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
por: Segura, Beatriz Tejera, et al.
Publicado: (2019)

Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort study
por: Croca, Sara, et al.
Publicado: (2014)

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome
por: McDonnell, Thomas C. R., et al.
Publicado: (2018)

Purified IgG from Patients with Obstetric but not IgG from Non-obstetric Antiphospholipid Syndrome Inhibit Trophoblast Invasion
por: Poulton, Katie, et al.
Publicado: (2015)

Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome
por: Cousins, Laura, et al.
Publicado: (2015)

Going viral in rheumatology: using social media to show that mechanistic research is relevant to patients with lupus and antiphospholipid syndrome
por: McDonnell, Thomas C R, et al.
Publicado: (2018)

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
por: Willis, Rohan, et al.
Publicado: (2022)

The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS
por: McDonnell, Thomas, et al.
Publicado: (2020)

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
por: Pericleous, Charis, et al.
Publicado: (2016)

Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis
por: Lambrianides, Anastasia, et al.
Publicado: (2011)

Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up
por: Luo, Weike, et al.
Publicado: (2022)

Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
por: Raimondo, Maria Gabriella, et al.
Publicado: (2017)

Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APS
por: McDonnell, Thomas, et al.
Publicado: (2015)

Domain I of β2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation
por: Albay, A, et al.
Publicado: (2019)

Systemic lupus erythematosus
por: Manson, Jessica J, et al.
Publicado: (2006)

IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Reshetnyak, Tatiana, et al.
Publicado: (2022)

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)

Cytokines in systemic lupus erythematosus, London, UK
por: Rahman, Anisur
Publicado: (2003)

Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome
por: Arachchillage, Deepa J., et al.
Publicado: (2023)

The Coexistence of Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Colombians
por: Franco, Juan-Sebastian, et al.
Publicado: (2014)

Pulmonary manifestations of systemic lupus erythematosus patients with and without antiphospholipid syndrome
por: Hamdani, Muhammad Afzal, et al.
Publicado: (2015)

Outcomes of membranous and proliferative lupus nephritis – analysis of a single-centre cohort with more than 30 years of follow-up
por: Farinha, Filipa, et al.
Publicado: (2020)

Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus
por: Bakshi, Jyoti, et al.
Publicado: (2022)

Menorrhagia: an underappreciated problem in pre-menopausal women with systemic lupus erythematosus
por: Wincup, C, et al.
Publicado: (2019)

Imaging Assessment of Cardiovascular Disease in Systemic Lupus Erythematosus
por: Croca, Sara C., et al.
Publicado: (2012)

Coexistence of pituitary macroadenoma with systemic lupus erythematosus and antiphospholipid syndrome
por: Valizadeh, Neda, et al.
Publicado: (2012)

Neutrophils—Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Wirestam, Lina, et al.
Publicado: (2019)

Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Reshetnyak, Tatiana, et al.
Publicado: (2023)

Systemic Lupus Erythematosus: Genomics, Mechanisms, and Therapies
por: Fernández-Nebro, Antonio, et al.
Publicado: (2012)

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study
por: Croca, Sara, et al.
Publicado: (2015)

Childhood-Onset Systemic Lupus Erythematosus Presenting With Concomitant Gastrointestinal Manifestation and Antiphospholipid Syndrome
por: Mohd Shukri, Nur Diyana, et al.
Publicado: (2023)

Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
por: Bakshi, Jyoti, et al.
Publicado: (2017)

Corticobasal Syndrome Associated with Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus
por: Hashimoto, Ritsuo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nqlvdgv9cj6ipcp62iv58spbu9